查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413374

去肾神经技术市场：按技术、按原因 - 2024-2030 年全球预测

Renal Denervation Technologies Market by Technology (Microinfusion, Radiofrequency, Ultrasound), Cause (Diabetes, Heart Failure, Hypertension) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年去肾神经技术市场规模为3.1144亿美元，2024年将达3.7415亿美元，2030年将达9.9333亿美元，复合年增长率为18.02%。

肾去神经技术的全球市场

主要市场统计
基准年[2023] 31144万美元
预测年份 [2024] 37415万美元
预测年份 [2030] 99333万美元
复合年增长率（%） 18.02%
去肾神经技术市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估去肾神经技术市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肾去神经技术市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-去肾神经技术市场的市场规模与预测是多少？

2-在肾臟去神经技术市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-去肾神经技术市场的技术趋势和法律规范是什么？

4-去肾神经技术市场主要供应商的市场占有率是多少？

5-进入去肾神经技术市场有哪些合适的型态与策略手段？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和高血压盛行率增加
      • 对微创手术的偏好增加
      • 扩大医疗保健支出和基础设施发展
    • 抑制因素
      • 去肾神经手术缺乏报销
    • 机会
      • 肾臟去神经技术的持续研究与研究
      • 新产品发布和多项监管核准
    • 任务
      • 缺乏与 RDN 手术相关的长期临床资料和风险
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章去肾臟神经技术市场：依技术分类

  • 微注射
  • 无线电频率
  • 超音波

第七章肾臟去神经技术市场的原因

  • 糖尿病
  • 心臟衰竭
  • 高血压

第八章 美洲去肾神经技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区去肾臟神经技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲去肾臟神经技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：按主要企业划分
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Ablative Solutions, Inc.
    • Boston Scientific Corporation
    • Cordis Corporation
    • Medtronic PLC
    • Mentice
    • Mercator Medsystems, Inc.
    • Otsuka Medical Devices Co., Ltd.
    • Recor Medical, Inc.
    • SoniVie Ltd.
    • Symple Surgical, Inc.
    • Terumo Corporation
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-02026C4CB085

[186 Pages Report] The Renal Denervation Technologies Market size was estimated at USD 311.44 million in 2023 and expected to reach USD 374.15 million in 2024, at a CAGR 18.02% to reach USD 993.33 million by 2030.

Global Renal Denervation Technologies Market

KEY MARKET STATISTICS
Base Year [2023] USD 311.44 million
Estimated Year [2024] USD 374.15 million
Forecast Year [2030] USD 993.33 million
CAGR (%) 18.02%
Renal Denervation Technologies Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Renal Denervation Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Renal Denervation Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., Boston Scientific Corporation, Cordis Corporation, Medtronic PLC, Mentice, Mercator Medsystems, Inc., Otsuka Medical Devices Co., Ltd., Recor Medical, Inc., SoniVie Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Microinfusion
    • Radiofrequency
    • Ultrasound
  • Cause
    • Diabetes
    • Heart Failure
    • Hypertension
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Renal Denervation Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Renal Denervation Technologies Market?

3. What are the technology trends and regulatory frameworks in the Renal Denervation Technologies Market?

4. What is the market share of the leading vendors in the Renal Denervation Technologies Market?

5. Which modes and strategic moves are suitable for entering the Renal Denervation Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Renal Denervation Technologies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and rising prevalence of hypertension
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Expanding healthcare spending and infrastructure improvement
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for renal denervation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing studies and research about renal denervation technologies
      • 5.1.3.2. New product launches and approvals by several regulatory agencies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of long-term clinical data and risks associated with RDN procedure
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Renal Denervation Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Microinfusion
  • 6.3. Radiofrequency
  • 6.4. Ultrasound

7. Renal Denervation Technologies Market, by Cause

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Heart Failure
  • 7.4. Hypertension

8. Americas Renal Denervation Technologies Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Renal Denervation Technologies Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Renal Denervation Technologies Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Ablative Solutions, Inc.
    • 12.1.3. Boston Scientific Corporation
    • 12.1.4. Cordis Corporation
    • 12.1.5. Medtronic PLC
    • 12.1.6. Mentice
    • 12.1.7. Mercator Medsystems, Inc.
    • 12.1.8. Otsuka Medical Devices Co., Ltd.
    • 12.1.9. Recor Medical, Inc.
    • 12.1.10. SoniVie Ltd.
    • 12.1.11. Symple Surgical, Inc.
    • 12.1.12. Terumo Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RENAL DENERVATION TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 7. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2030 (%)
  • FIGURE 10. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY MICROINFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 10. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 99. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. RENAL DENERVATION TECHNOLOGIES MARKET LICENSE & PRICING